Drug Profile
MGN 17xx series - Mologen
Alternative Names: MGN-1706; MGN-17xxLatest Information Update: 12 Feb 2014
Price :
$50
*
At a glance
- Originator Mologen
- Class
- Mechanism of Action Immunomodulators; Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 12 Feb 2014 No development reported - Phase-I for Cancer in Germany (SC)
- 17 Jan 2011 Phase I development in Cancer is ongoing in Germany
- 30 Jan 2009 Phase-I clinical trials in Prostate cancer in Germany (IV)